3rd Jun 2008 15:03
RNS Number : 8701V
Dechra Pharmaceuticals PLC
03 June 2008
DECHRA PHARMACEUTICALS PLC
(the Company)
Director Shareholding
The Company has been informed that Mr I D Page, a director of the Company, yesterday exercised SAYE options over 42,115 ordinary shares of 1p each ("Ordinary Share") at an exercise price of £0.39 per share. Following this transaction, Mr Page's beneficial interest has increased to 759,332 Ordinary Shares, which represents approximately 1.17% per cent. of the Company's issued ordinary share capital.
3 June 2008
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
DPH.L